Great to see York Press spotlight the £2.5m awarded last year to CBR members for blood cancer research - continued recognition of work driving better understanding and future treatments
#BloodCancerResearch #CBR #YorkScience #ResearchImpact
www.yorkpress.co.uk/news/2582263...
Blood cancer patients faced higher COVID-19 mortality, but shielding & vaccines saved lives. Some subgroups need better protection strategies for future pandemics
Vaccination helped:
There was a clear benefit overall, but limited effect in CLL & MCL patients. The findings suggest tailored strategies for vulnerable groups that are important beyond COVID-19.
#Immunology #CancerCare
Shielding mattered:
Early excess deaths in patients with MBL (premalignancy) occurred because they weren’t advised to shield initially - unlike those with malignancies. This showcases a gap in healthcare-related policy.
#PublicHealth
Mortality risk:
Haematology patients: 2.59% COVID-19 deaths
General population: 1.65%
Risks were higher in men, older age, and those with co-morbidities.
#BloodCancer #Epidemiology
New study from CBR Leaders and BRC collaborators on COVID-19 mortality in patients with blood cancers vs the general population (UK cohort, ~4M people)
pubmed.ncbi.nlm.nih.gov/41220109/
#COVID19 #Haematology
Exciting news! 🎉 We'd like to welcome Professor Ian Hitchcock as our new Director. With a passion for innovation and collaboration, @ian-hitchcock.bsky.social will lead us into an inspiring new chapter of research excellence
Great to see key partners from York and Leeds at the BRC Haematology Theme meeting today at the National STEM Learning Centre
Colleagues gathered to discuss recent progress, data, and results from their research on immunosenescence, inflammation, clonal haematopoiesis, and epidemiology
Research conducted by our Director @ian-hitchcock.bsky.social's collaborators in Oxford has found that platelets could help make cancer-detecting blood tests much more effective
Read more about the study on @cancerresearchuk.org website
news.cancerresearchuk.org/2025/08/14/p...
Read more about the research in the press coverage on our website: york.ac.uk/news-and-eve...
You can also read the publication here: haematologica.org/article/view...
The findings have been published during Blood Cancer Awareness Month. Myeloma affects around 6,300 people in the UK every year, making up around 2% of all cancer cases. Currently there is no cure, but treatment can help to manage symptoms and extend life
This research was led by our leaders in Health Sciences
& funded by @cancerresearchuk.org
and @bloodcanceruk.bsky.social
The study found that median survival for people with myeloma rose from 2.4 years in 2005 to 4.5 years in 2019
People diagnosed with multiple myeloma – one of the most common forms of blood cancer – are now living nearly twice as long on average as they were in 2005, according to a new study. The findings, published in Haematologica, are based on data from more than 3,700 UK patients in England
One rose will be sent to London on behalf of each person who pledges their support, with each rose representing the region’s call for better prevention, earlier diagnosis, improved treatment & fairer research funding for Yorkshire
Along with Yorkshire Cancer Research, Generation Research are urging people to 'Stand with Yorkshire' and call for the Government to invest now for a cancer-free future in Yorkshire, and beyond
Send a white rose to London:
www.yorkshirecancerresearch.org.uk/campaigning/...
Generation Research Founder Jillian Barlow answered the questions:
❔ What do we mean by clinical research?
❔How can we build better research ecosystems & what does "better" mean?
❔How do we solve inequity in healthcare by supporting biomedical scientists from diverse backgrounds?
...through initaitives such as Active Together (Liam Humphreys), Yorkshire Lung Screening Trial (with Matthew Callister) and Yorkshire Enhanced Stop Smoking Study
This is all dependent on innovative regional clinical research
But who are our future clinical researchers?
Yorkshire Cancer Research hosted the White Rose Cancer Report launch event in Sheffield on 3rd July
Yorkshire is one of the regions hardest hit by cancer
Karen, David and Geoff shared their positive experiences, and how patient-centric care has literally saved their lives
(1/4) Three new pieces of research have been published from the ProteoStem ( www.proteostem.co.uk ) research group @billgrey.bsky.social working in @biologyatyork.bsky.social @ybri-uoy.bsky.social @cbr-uoy.bsky.social
Congratulations to @bridgekatherine.bsky.social who has been awarded an @The_MRC New Investigator Research Grant! This £0.83M award will enable her laboratory to research hijacked hypoxia signalling in blood cancer @ybri-uoy.bsky.social @biologyatyork.bsky.social
Blood Cancer Survivor and founder of the York Haematology Support Group Carol Miller told That's TV why she thinks being part of a community can help people manage the anxiety of receiving a diagnosis.
www.york.ac.uk/biomedical-r...
We will share good news, public events, research opportunities & the latest publications from the CBR, all related to our research programmes:
💉Experimental Haematology
👩⚕️Clinical
🌍Epidemiology
Follow us to connect with our community of researchers who's work drives transformative blood research!
